Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer - Authors' reply

Research output: Contribution to journalComment/debateResearchpeer-review

  1. Immune Cell Profiling of Peripheral Blood as Signature for Response During Checkpoint Inhibition Across Cancer Types

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Phase 1 study of the immunotoxin LMB-100 in patients with mesothelioma and other solid tumors expressing mesothelin

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Larotrectinib versus Prior Therapies in Tropomyosin Receptor Kinase Fusion Cancer: An Intra-Patient Comparative Analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Vivek Subbiah
  • Ulrik Lassen
  • Eduard Gasal
  • Paul Burgess
  • Zev A Wainberg
View graph of relations
Original languageEnglish
JournalLancet Oncology
Volume21
Issue number11
Pages (from-to)e516
ISSN1470-2045
DOIs
Publication statusPublished - Nov 2020

ID: 62313285